The news media have recently focused a great deal of attention on insurance coverage for treatment of mental disorders. Reports of unusually large increaces in expenditures for mental health care under private insurance plans have appeared in major newspapers and trade publications. 1 These reports have pointed to mental disorders, defined to include psychiatric and substance abuse diagnoses, as disproportionate contributors to rising health insurance premiums. Reports from benefits consulting firms such as A. Foster Higgins have cited increases of between 18 and 27 percent Curing [1987] [1988] [1989] . These data form the basis of proposals to devote special attention to mental health care use via managed care arrangements and to place new limits on insurance coverage for treatment of mental disorders. 2 These claims are based on surveys of insurance benefits managers for major employers, not on any direct observation of use and expenditures. The Foster Higgins survey has attracted the most attention. Only 18 percent of the benefits managers responding to the survey answered the question regarding mental health costs. Among those who did respond, approximately half indicated that they did not know the cost of mental health care. In this DataWatch, we examine recent changes in mental health care spending and usage, using information obtained directly from insurance and hospital records. We address these issues by relying on (1) a sample composed of the claims experience of employees of mid-to large-sized U.S. firms during 1986-1989, and (2) data from two state hospital discharge abstract data systems.
Our review of these data produces a much more complicated view of recent trends in use of mental health care than has appeared in the popular press. The implication here is that solutions to rising expenditures for mental health care require targeted interventions aimed at D ATAWATCH 117 containing costs in areas that have experienced unusual rates of growth in expenditures.
Data Used In The Analysis
We used three data sets to assess recent trends in spending and use of mental health care: data furnished by MEDSTAT Systems, which processes health insurance claims data for major U.S. corporations; data from hospital discharge records collected for all general hospitals in Maryland; and data from hospital discharge records for all hospitals in Washington State.
The MEDSTAT data consist of the employees and dependents of several major corporations distributed across the major geographic regions of the nation and from diverse industries. During 1986-1989, the total number of persons enrolled in these insurance plans ranged from 987,000 to 1.3 million. This represented all employees and dependents of participating firms except those covered by staff-model health maintenance organizations (HMOs). All health plans reflected in the data are self-insured. The specific arrangements for administering the self-insured plan vary considerably and include the use of third-party administrators. Ninety-five percent of the contract holders (employees) are employed by a manufacturing concern The data are therefore not reflective of the U.S. population, yet they do provide information on costs and use for a large and relatively well insured segment of the population.
All employee and dependent health care claims from any source are included in the data. Substance abuse and psychiatric treatment were covered by the health benefit plans during the study period, and benefits during 1986-1988 did not change. At the beginning of 1989, benefits changed significantly for a portion of the population. Data on total, inpatient, and outpatient claims were available in the MEDSTAT data set. Utilization and expenditure data were also disaggregated by major diagnostic categories (MDCs) from the diagnosis-related group (DRG) classification system. In addition, it was possible to disaggregate inpatient care by age group for most of the population.
The Maryland Health Services Cost Review Commission, the state's hospital rate-setting agency, requires all acute care general hospitals to report information on all discharges. (A sample of these data are audited annually to maintain accuracy of information.) We examined data reflecting the experiences of discharges paid for by private insurance (Blue Cross and commercial carriers). Detailed information on diagnosis, charges, days of care, and patient demographics are available for each discharge. This analysis examined 257,731 discharges for 1986 and 257,881 for 1988 to evaluate recent trends in hospital use.
As in Maryland, all hospitals in Washington State must submit a discharge abstract for each patient treated. The abstract contains information on days of care, charges, patient demographics, and diagnosis. All hospitals are required to provide discharge abstract information, not just acute care general hospitals, as is true in Maryland. This means that data from private psychiatric hospitals are included for Washington and not for Maryland. We also note that free-standing nonhospital providers of residential mental health and substance abuse care are excluded from both data sets. Hospital utilization patterns in Washington for 1986 and 1988 were compared for patients covered by commercial insurers. This comparison involved 95,056 discharges in 1986 and 119,400 in 1988.
The use of three separate databases allows us to make some general observations about overall trends in private insurance use and spending for mental health care. We then examine inpatient utilization more specifically, since it has been the focus of considerable public attention.
Results
MEDSTAT data. The MEDSTAT database represents the claims experience for the full set of employers who reported 1986 information (Exhibit 1). The mental health insurance coverage offered by these employers remained the same between 1986 and 1988. Beginning in 1989, a thirty-day annual limit was placed on reimbursable inpatient days for mental health care, and the outpatient benefit was constrained by the imposition of a thirty-visit annual limit and a variable copayment schedule. These changes affected approximately half of the study population. We therefore caculate changes in charges for 1986-1988 and 1988-1989 separately.
During 1986-1988, charges for psychiatric (MDC 19) and substance abuse (MDC 20) care rose at rates substantially above the rate for all health care-20.1 percent and 32.4 percent, respectively, compared with an overall rate of increase of 13.0 percent. Regarding data on inpatient care for 1986-1988, several findings are notable. First, charges for inpatient care for both psychiatric and substance abuse problems increased more rapidly than did charges for all inpatient care. Second, most of the increase in payments (72 percent) for psychiatric care between 1986 and 1988 was due to an increase in utilization by juveniles (under age eighteen). Third, charges and payments for inpatient treatment for substance abuse grew at high rates for both adults and juveniles.
The trends in charges and payments are reported as percentages of total charges and payments. They reflect real increases in use, particularly in Outpatient treatment charges for psychiatric (MDC 19) diagnoses increased considerably more rapidly than did all outpatient charges (12.2 percent versus 7.4 percent). The rates of increase in charges per enrollee for both psychiatric outpatient care and overall outpatient care are lower than the growth in total charges per enrollee. Charges for outpatient substance abuse care grew much faster than did overall outpatient charges (53.4 percent) during 1986-1988.
The changes in charges and payments for 1989 reported in Exhibit 1 reflect the insurance benefit changes imposed on mental health care. In particular, the declines in inpatient use for both psychiatric and substance abuse diagnoses reflect sharp declines in inpatient use by those segments of the study population that were subject to the thirty-day annual limit on reimbursable inpatient days. Previous research has shown that the length-of-stay of psychiatric inpatients is quite sensitive to the imposition of day limits. 3 The sharp decline in payments for inpatient care of juveniles with psychiatric diagnoses indicates that limits were very effective in reducing use by those segments of the population that were responsible for the 1986-1988 increases.
The outpatient care experience for 1988-1989 differs substantially from the overall changes in charges. Outpatient charges for all diagnoses increased by 38.5 percent, compared with increases of 11.3 percent and 25.1 percent for psychiatric and substance abuse diagnoses, respectively. The rates of increase in charges for mental health care were lower for 1988-1989 than for 1986-1988. This again reflects the additional cost sharing and benefit limitations introduced in 1989.
Since the changes in benefit design between 1988 and 1989 appear to have been important, we also examine the expenditure trends for the segment of the enrollee population for whom benefits did not change (referred to as the constant benefit group). For this group, the overall rate of increase in expenditure on all health care was 15.5 percent from 1988 to 1989. The corresponding growth rates in spending for psychiatric and substance abuse care were only 6.6 percent and 4.6 percent, respectively. Inpatient expenditures on mental health care (both diagnoses together) grew slightly less rapidly than did overall inpatient spending. In interpreting the results for the constant benefit group, it is important to bear in mind that they are a selected subset of our total database. Comparing 1989 total charges per capita shows that the constant benefit group is more expensive on average ($1,489.21) than the totalgroup ($1,289.72). The corresponding difference for 1988 is $1,289.10 versus $1,152.56.
State data. The utilization data for privately insured residents of Maryland and Washington State are presented as percentages of inpatient utilization for all conditions (Exhibit 2). 4 Overall charge levels for all mental disorders have not increased relative to other inpatient utilization (the cost per inpatient admission in Maryland is roughly 7 percent below the national average). However, the composition of mental health charges is changing.
The portion of all inpatient days that are for mental health care has increased modestly in Maryland. There have been no increases in inpatient care for individuals with psychiatric (MDC 19) diagnoses relative to all conditions. Also, the entire increase in the share of inpatient days devoted to treatment of mental disorders is due to increases in care for substance abuse. We observed no unusual increases in utilization by juveniles in Maryland.
The data for Washington State yield a qualitatively similar pattern in utilization trend: (Exhibit 2). The share of inpatient charges attributable to mental disorders has increased slightly. The data suggest a significant shift in the composition of mental health charges from psychiatric conditions to substance abuse. The entire increase of 24.5 percent in the share of total inpatient days devoted to mental health care is attributable to treatment of substance abuse. Finally, inpatient mental health care to juveniles did not expand at greater rates than did all inpatient care. The data from the two state discharge abstract data sets differ somewhat from what we observed using the MEDSTAT database. Specifically, the large increases in juveniles' use of psychiatric inpatient treatment found in the MEDSTAT data were not observed in either Maryland or Washington. The significant increases in substance abuse treatment are common to all data sets, as are the rates of increase in adult psychiatric inpatient care, which are below increases for all inpatient care. The differences between the two state data sets and the MEDSTAT data may be due in part to two key features of the hospital sector in Maryland and Washington. First, neither has an abundance of private psychiatric hospitals. Second, the hospital industries in Maryland and Washington are subject to relatively more intense regulation than in most other states.
Discussion
Examination of the three data sources described above leads us to three important conclusions. First, the use of inpatient care for treatment of adult psychiatric disorders (MDC 19) has grown less rapidly than has inpatient care for all health conditions. Second, growth of charges and use of inpatient treatment for substance abuse has grown at exceptional rates. Third, charges for outpatient substance abuse treatment are also growing at rates well above the rate of growth for treatment of other conditions. A secondary, less certain, finding is that there has been significant growth in inpatient psychiatric use by juveniles.
Rising insurance premiums are of concern to employers, workers, and government alike. The results found for 1988-1989 show that employers can limit their liability by withdrawing coverage. The evidence reported above shows that limits were most effective in curtailing use of inpatient care. This raises the broader question, to what extent such policies reduce "inappropriate" care versus the degree to which they withdraw insurance protection against legitimate risks. A related issue is the extent to which imposing such limits results in cost shifting from insurers to enrollees and taxpayers. If usage persists in the absence of coverage, then imposing limits does not primarily reduce costs; rather, it shifts the responsibility for paying for care. Rapidly rising levels of uncompensated psychiatric care and increasing use of publicly provided psychiatric care suggest that cost savings from some cost containment efforts may appear deceptively lar ge. 5 There are many legitimate concerns regarding the escalation of use and costs of mental health services. The uncertain effectiveness of various treatment modalities may not appear to justify the wide differences in costs. Extraordinary rates of increase in inpatient psychiatric treatment of adolescents reported here and elsewhere require special scrutiny. The forces leading to such dramatic changes in use remain mysterious. Perhaps they are driven in part by the growth of for-profit hospital programs and aggressive marketing campaigns. 6 They may also be the result of an increased recognition of extraordinary needs that are now unmet in the community. Conservative estimates have indicated that about 12 percent of the nation's children, or nearly eight million people under age eighteen, need mental health services. 7 These issues require further research and the close attention of both private and public policymakers.
Our findings suggest that not all parts of mental health care are experiencing unusual increases in treatment costs. Therefore, cutting all mental health benefits penalizes appropriate as well as inappropriate users of services in the private sector. Needy individuals may then suffer from D ATAWATCH 123 undertreatment, shifts to the public sector, and increased illness and death.
Mental health benefits, which are often the latest additions to an insurance policy, are targeted for cutbacks because of insurance premium increases. It is important to note in the MEDSTAT data that increases in mental health charges contributed only 2.5 percentage points of the 13 percent increase in health charges between 1986 and 1988. The changes between 1988 and 1989 illustrate that when policies are undertaken to strictly limit mental health benefits, this cuts increases in mental health spending but does little to reduce growth in overall charges, which continue to rise at a rate of close to 12 percent. Further research is needed on the dynamics of utilization and expenditure in private insurance when mental health benefits are limited or eliminated.
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